Ketoprofen
About Ketoprofen
Ketoprofen is a widely used nonsteroidal anti inflammatory drug (NSAID) with global presence in generic and brand formulations, reflecting ongoing trends in analgesia, OTC access, and regulatory scrutiny of NSAIDs.
Trend Decomposition
Trigger: Rising demand for effective, affordable pain relief and ongoing scrutiny of NSAID safety profiles drive attention to ketoprofen as a cost effective option.
Behavior change: Patients increasingly compare NSAIDs for safety and cost, while clinicians consider ketoprofen as an alternative in specific indications.
Enabler: Large scale generic manufacturing and established supply chains reduce cost and increase availability of ketoprofen.
Constraint removed: Lower production costs and broader formulations remove barriers to access for patients and healthcare providers.
PESTLE Analysis
Political: Regulatory harmonization and pharmacovigilance requirements influence ketoprofen approval and post market surveillance.
Economic: Price competition among generics lowers treatment costs and expands affordability.
Social: Growing emphasis on accessible pain management and self care drives consumer uptake of OTC NSAIDs like ketoprofen.
Technological: Advances in formulation science enable improved bioavailability and safer over the counter products.
Legal: Compliance with labeling, safety warnings, and contraindications shapes marketing and patient use.
Environmental: Responsible manufacturing and waste management for pharmaceutical products influence sustainability considerations.
Jobs to be done framework
What problem does this trend help solve?
Provides affordable, effective pain relief for common inflammatory conditions.What workaround existed before?
Consumers relied on other NSAIDs or higher cost alternatives, with varying safety and efficacy profiles.What outcome matters most?
Cost efficiency and reliable relief with acceptable safety.Consumer Trend canvas
Basic Need: Accessible, effective analgesia.
Drivers of Change: Generic competition, price sensitivity, and regulatory focus on NSAID safety.
Emerging Consumer Needs: Clear safety information and convenient dosing forms.
New Consumer Expectations: Transparent risk/benefit profiles and predictable affordability.
Inspirations / Signals: Broad generics pipelines and consumer demand for cost effective therapies.
Innovations Emerging: Improved topical formulations and combination products for safer use.
Companies to watch
- Teva Pharmaceutical Industries - Major generic manufacturer with ketoprofen API and finished dose products in multiple markets.
- Sandoz (Novartis division) - Global generic specialist producing ketoprofen formulations and APIs.
- Mylan (Viatris)** - Large generics company offering ketoprofen products in various regions.
- Dr. Reddy's Laboratories - Active in ketoprofen generic market across multiple territories.
- Sun Pharmaceutical Industries - Produces ketoprofen formulations as part of its broad analgesic portfolio.
- Lupin Limited - Generics manufacturer with ketoprofen products available in several markets.
- Aurobindo Pharma - Manufactures ketoprofen API and formulations for global markets.
- Zydus Cadila - Indian pharmaceutical company with ketoprofen products in portfolio.
- Torrent Pharmaceuticals - Produces ketoprofen based formulations and generics.
- Pfizer (legacy brands and APIs in certain regions) - Historically involved in NSAID manufacturing and distribution, including ketoprofen in some markets.